Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression

Trends in Cell Biology

Volumn 25, Issue 11, 2015, Pages 675-686

  Ye, Xin ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cancer stem cells; EMT (epithelial mesenchymal transition); Plasticity; Tumor progression

Indexed keywords

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CARCINOMA CELL; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; EPITHELIAL MESENCHYMAL PLASTICITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; INTRACELLULAR SIGNALING; MESENCHYME CELL; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR INVASION; ANIMAL; CELL MOTION; DISEASE COURSE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANIMALS; CELL MOVEMENT; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR CELLS, CULTURED;

EID: 84945566252     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2015.07.012     Document Type: Review

References (82)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
3. Nieto M.A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013, 342:1234850.
4. Thiery J.P., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
5. Nieto M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 2011, 27:347-376.
6. Tam P.P., Behringer R.R. Mouse gastrulation: the formation of a mammalian body plan. Mech. Dev. 1997, 68:3-25.
7. Savagner P., et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J. Cell Physiol. 2005, 202:858-866.
8. Grunert S., et al. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 2003, 4:657-665.
9. Theveneau E., et al. Collective chemotaxis requires contact-dependent cell polarity. Dev. Cell 2010, 19:39-53.
10. Guo W., et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012, 148:1015-1028.
11. Mani S.A., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
12. Morel A.P., et al. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 2012, 8:e1002723.
13. Morel A.P., et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3:e2888.
14. Scheel C., et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011, 145:926-940.
15. Blanpain C., et al. Epithelial stem cells: turning over new leaves. Cell 2007, 128:445-458.
16. Shackleton M., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
17. Stingl J., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
18. Nassour M., et al. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS ONE 2012, 7:e53498.
19. Shirley S.H., et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
20. Huber M.A., et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17:548-558.
21. Rhim A.D., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
22. Sarrio D., et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68:989-997.
23. Aleskandarany M.A., et al. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res. Treat. 2014, 145:339-348.
24. Blanco M.J., et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21:3241-3246.
25. Blick T., et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 2008, 25:629-642.
26. Choi Y., et al. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Hum. Pathol. 2013, 44:2581-2589.
27. Roy S.S., et al. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene 2014, 33:3707-3716.
28. Wu Y., et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
29. Yang J., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
30. Zhang K., et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol. 2013, 15:677-687.
31. Tran H.D., et al. Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 2014, 74:6330-6340.
32. Cheng Q., et al. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Res. 2014, 16:407.
33. Creighton C.J., et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13820-13825.
34. Oliveras-Ferraros C., et al. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 2012, 11:4020-4032.
35. Moody S.E., et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8:197-209.
36. Creighton C.J., et al. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:253-260.
37. Chaffer C.L., et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74.
38. Kudo-Saito C., et al. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206.
39. Akalay I., et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013, 73:2418-2427.
40. Akalay I., et al. Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. Oncogene 2015, 34:2261-2271.
41. Chen L., et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat. Commun. 2014, 5:5241.
42. Tarin D., et al. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005, 65:5996-6000. discussion 6000-5991.
43. Yu M., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
44. Husemann Y., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
45. Raimondi C., et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res. Treat. 2011, 130:449-455.
46. Kahlert U.D., et al. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett. 2013, 331:131-138.
47. Tso C.L., et al. Primary glioblastomas express mesenchymal stem-like properties. Mol. Cancer Res. 2006, 4:607-619.
48. Chang H.Y., et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12877-12882.
49. Battula V.L., et al. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 2010, 28:1435-1445.
50. Ocana O.H., et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012, 22:709-724.
51. Stankic M., et al. TGF-beta-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Rep. 2013, 5:1228-1242.
52. Tsai J.H., et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012, 22:725-736.
53. Schmidt J.M., et al. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation. Cell Rep. 2015, 10:131-139.
54. Oft M., et al. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 1998, 8:1243-1252.
55. Li H.J., et al. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2012, 2:840-855.
56. Lu H., et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat. Cell Biol. 2014, 16:1105-1117.
57. Su S., et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014, 25:605-620.
58. Labelle M., et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590.
59. Brabletz S., Brabletz T. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?. EMBO Rep. 2010, 11:670-677.
60. Burk U., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
61. Hill L., et al. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int. J. Cancer 2013, 132:745-754.
62. Brabletz T. MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity/EMT governed by p53. Cell Cycle 2012, 11:215-216.
63. Kim N.H., et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 2011, 195:417-433.
64. Shapiro I.M., et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011, 7:e1002218.
65. Tam W.L., Weinberg R.A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 2013, 19:1438-1449.
66. Lin Y., et al. Epigenetic regulation of EMT: the Snail story. Curr. Pharm. Des. 2014, 20:1698-1705.
67. Shaul Y.D., et al. Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 2014, 158:1094-1109.
68. Fidler I.J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 1978, 38:2651-2660.
69. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
70. Calabrese P., et al. Pretumor progression: clonal evolution of human stem cell populations. Am. J. Pathol. 2004, 164:1337-1346.
71. Jones S., et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4283-4288.
72. Klein C.A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 2009, 9:302-312.
73. Cameron M.D., et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 2000, 60:2541-2546.
74. Chambers A.F., et al. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
75. Luzzi K.J., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 1998, 153:865-873.
76. Malanchi I., et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012, 481:85-89.
77. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
78. Chaffer C.L., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7950-7955.
79. Gupta P.B., et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146:633-644.
80. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
81. Gupta P.B., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
82. Caramel J., et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 2013, 24:466-480.